School of Medicine and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298-0230, USA.
J Clin Oncol. 2010 Jan 10;28(2):299-304. doi: 10.1200/JCO.2009.24.6397. Epub 2009 Nov 23.
Many seriously ill patients with cancer do not discuss prognosis or advance directives (ADs), which may lead to inappropriate and/or unwanted aggressive care at the end of life. Ten years ago, patients with cancer said they would not like to discuss ADs with their oncologist but would be willing to discuss them with an admitting physician. We assessed whether this point of view still held.
Semi-structured interviews were conducted with 75 consecutively admitted patients with cancer in the cancer inpatient service.
Of those enrolled, 41% (31 of 75) had an AD. Nearly all (87%, 65 of 75) thought it acceptable to discuss ADs with the admitting physician with whom they had no prior relationship, and 95% (62 of 65) thought that discussing AD issues was very or somewhat important. Only 7% (5 of 75) had discussed ADs with their oncologist, and only 23% (16 of 70) would like to discuss ADs with their oncologist. When specifically asked which physician they would choose, 48% (36 of 75) of patients would prefer their oncologist, and 35% (26 of 75) would prefer their primary care physician.
Fewer than half of seriously ill patients with cancer admitted to an oncology service have an AD. Only 23% (16 of 70) would like to discuss their ADs with their oncologist but nearly all supported a policy of discussing ADs with their admitting physician. However, fully 48% (36 of 75) actually preferred to discuss advance directives with their oncologist if AD discussion was necessary. We must educate patients on why communicating their ADs is beneficial and train primary care physicians, house staff, hospitalists, and oncologists to initiate these difficult discussions.
许多身患癌症的重病患者并未讨论过预后或预先指示(AD),这可能导致他们在生命末期接受不适当且/或不必要的积极治疗。十年前,癌症患者表示他们不愿与肿瘤医生讨论 AD,但愿意与主治医生讨论 AD。我们评估了这种观点是否仍然成立。
对癌症住院服务部的 75 名连续入院的癌症患者进行了半结构化访谈。
在纳入的患者中,有 41%(75 例中有 31 例)有 AD。几乎所有人(87%,65/75)认为与他们没有先前关系的主治医生讨论 AD 是可以接受的,95%(62/65)认为讨论 AD 问题非常重要或有些重要。只有 7%(75 例中有 5 例)与肿瘤医生讨论过 AD,只有 23%(70 例中有 16 例)愿意与肿瘤医生讨论 AD。当被具体问到他们愿意与哪位医生讨论 AD 时,48%(75 例中有 36 例)的患者会选择他们的肿瘤医生,35%(75 例中有 26 例)会选择他们的初级保健医生。
在被收入肿瘤科的重病患者中,不到一半的人有 AD。只有 23%(70 例中有 16 例)愿意与肿瘤医生讨论他们的 AD,但几乎所有人都支持与主治医生讨论 AD 的政策。然而,如果需要讨论 AD,实际上有 48%(75 例中有 36 例)的患者更愿意与肿瘤医生讨论 AD。我们必须教育患者为什么沟通他们的 AD 是有益的,并培训初级保健医生、住院医师、医院医师和肿瘤医生来启动这些困难的讨论。